investors media Rigel Pharmaceuticals Investor Relations Home

Researches and develops novel, small-molecule drugs on a mission to bring important therapeutics to the market.

OVERVIEW

This domain ir.rigel.com presently has a traffic classification of zero (the lower the more users). We have explored zero pages within the website ir.rigel.com and found forty-two websites referring to ir.rigel.com. We were able to observe three public web sites linked to this website.
Links to this site
42
Social Links
3

IR.RIGEL.COM RANKINGS

This domain ir.rigel.com is seeing variant levels of traffic throughout the the year.
Traffic for ir.rigel.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.rigel.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.rigel.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

WHAT DOES IR.RIGEL.COM LOOK LIKE?

Desktop Screenshot of ir.rigel.com Mobile Screenshot of ir.rigel.com Tablet Screenshot of ir.rigel.com

IR.RIGEL.COM HOST

We diagnosed that the main root page on ir.rigel.com took zero milliseconds to come up. We could not find a SSL certificate, so therefore our crawlers consider this site not secure.
Load time
0 secs
SSL
NOT SECURE
Internet Protocol
23.12.41.8

PAGE TITLE

investors media Rigel Pharmaceuticals Investor Relations Home

DESCRIPTION

Researches and develops novel, small-molecule drugs on a mission to bring important therapeutics to the market.

CONTENT

This domain had the following in the web page, "Q2 2015 Rigel Pharmaceuticals Inc." We observed that the web page stated " Data as of 080715Â 400 pm ET." It also stated " Rigel Announces Second Quarter 2015 Financial Results. Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results. There are currently no events scheduled. Q2 2015 Rigel Pharmaceuticals Inc. Rigel Announces Second Quarter 2015 Financial Results. Â Â Follow Us On." The header had rigel as the highest ranking keyword. It was followed by rigel pharmaceuticals, rigel pharma, and novel small molecule which isn't as ranked as highly as rigel. The next words the site uses is small molecule. drug discovery was also included and could not be seen by search engines.

VIEW OTHER WEB SITES

Riverbed Investor Relations Investor Relations

Detecting and Fixing Performance Issues. Business Continuity and Disaster Recovery.

DSpace Home

Welcome to the new Manakin interface to the DSpace digital repository. DSpace is a digital service that collects, preserves, and distributes digital material. Enter some text in the box below to search DSpace. Select a community to browse its collections.

Investor Relations Rockwell Medical, Inc.

Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology. Rockwell Medical Reports Fourth Quarter and Year End 2017 Results.